Explore the latest in rheumatoid arthritis, including recent advances in treatment of RA and in prevention of its systemic complications.
The meta-analysis investigates the association of conventional antirheumatic drugs and glucocorticoids with clinical outcomes among patients with rheumatoid arthritis.
This cohort study assesses the association between the risk of aortic stenosis and rheumatoid arthritis.
This cohort study evaluates the association between the presence of antidrug antibodies and response to biologic disease–modifying antirheumatic drugs, including adalimumab, infliximab, etanercept, tocilizumab, and rituximab, in adults with rheumatoid arthritis (RA).
This individual participant data meta-analysis estimates patient-specific outcomes of adding biologics to conventional synthetic disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis.
This comparative effectiveness reseach study assesses the effecetiveness of adalimumab vs tofacitinib for treatment of rheumatoid arthiritis in the clinical setting.
This cohort study evaluates the associations of rheumatoid arthritis and its seropositivity with subsequent Parkinson disease risk in a nationally representative Korean population.
This systematic review and meta-analysis assesses the efficacy, safety, and immunogenicity associated with biosimilars of adalimumab, etanercept, and infliximab compared with their reference biologics for patients with rheumatoid arthritis.
This randomized clinical trial investigates whether using digital health applications to assess patient-reported outcomes could result in disease control in patients with rheumatoid arthritis at 22 tertiary hospitals in China.
This open-label randomized clinical trial assessed the 12-month risk of disease activity flares after discontinuation of conventional synthetic DMARDs (csDMARDs) compared with continuing half-dose csDMARDs in adult Norwegian patients with rheumatoid arthritis and excellent disease control.
This cohort study evaluates the incidence of interstitial lung disease in patients with rheumatoid arthritis who have been treated with biologic and targeted synthetic disease-modifying antirheumatic drugs.
This cohort study assesses the prevalence of meeting successive markers of quality care for individuals with rheumatoid arthritis and characteristics associated with meeting these markers.
This cross-sectional survey study assesses whether hard rock underground mining and other mining industry occupations are associated with increased risk of rheumatoid arthritis using a population-based survey of men in counties of Colorado, New Mexico, and Utah with mining activity and high rates of silicosis-related mortality.
This diagnostic/prognostic study presents assesses machine learning algorithms submitted to an international crowdsourcing contest to develop methos to automatically quantify radiographic evidence of damage in patients with rheumatoid arthritis (RA).
This cohort study compares the delays in tumor necrosis factor inhibitor (TNFi) initiation because of insurance among children enrolled in public and private insurance plans.
This cohort study compares incidence of Alzheimer disease and related dementia among Medicare patients with rheumatoid arthritis using disease-modifying antirheumatic drugs.
This JAMA Patient Page describes the risk factors, signs and symptoms, diagnosis, treatment, and prognosis factors of rheumatoid arthritis.
This cohort study examines whether seropositive rheumatoid arthritis is associated with an increased risk of subsequently developing primary open-angle glaucoma among adults in Korea.
This cohort study compares COVID-19 incidence, risk, outcome severity, and treatment response between immunocompromised individuals and those without immune dysfunction conditions before and after SARS-CoV-2 vaccination.
This randomized clinical trial assesses the effect of therapeutic drug monitoring vs standard therapy on sustained disease control without disease worsening among patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) undergoing maintenance therapy with infliximab.
Customize your JAMA Network experience by selecting one or more topics from the list below.